Hyperglycaemia in acute stroke - To treat or not to treat

Cerebrovascular Diseases

Volumn 27, Issue SUPPL. 1, 2009, Pages 148-155

  Quinn, T J ^a,b   Lees, K R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

Acute stroke; Diabetes mellitus; Glucose; Hyperglycaemia; Stroke outcome; Thrombolysis

Indexed keywords

GLUCOSE; INSULIN; PIOGLITAZONE; POTASSIUM; THIAZOLIDINE DERIVATIVE; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD BRAIN BARRIER; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY CARE UNIT; CRITICAL ILLNESS; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEFICIENCY; MONOTHERAPY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; STROKE;

BLOOD GLUCOSE; CRITICAL ILLNESS; DIABETES MELLITUS; GLUCOSE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; PATIENT SELECTION; POTASSIUM; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 64149131116     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000200453     Document Type: Conference Paper

References (67)

1. Turner RC, Cull CA, Frighi V, Holman RR: Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999;281:2005-2012.
2. Lees KR, Walters MR: Acute Stroke and Diabetes. Cerebrovasc Dis 2005;20(suppl 1):9-14.
3. Oppenheimer SM, Hoffbrand B, Oswald GA, Yudkin JS: Diabetes mellitus and early morta lit y f rom stroke. BMJ 1985;291:1014-1015.
4. Mankovsky BN, Metzger BE, Molitch ME, Biller J: Cerebrovascular disorders in patients with diabetes mellitus. J Diabetes Complications 1996;10:228-242.
5. Feskens EJM, Kromhout D: Cardiovascular risk factors and the 25-year incidence of diabetes mellitus in middle aged men. Am J Epidemiol 1989;130:1101-1108.
6. Harris MI: Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993; 16:642-652.
7. Gray CS, Scott JF, French JM, Alberti KG, O'Connell JE: Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke. Age Ageing 20 04;3:71-77.
8. Bravata DM, Kim N, Concato J, Brass LM: Hyperglycaemia in patients with acute ischaemic stroke: how often do we screen for undiagnosed diabetes? Q J Med 2003;96:491-497.
9. Melamed E: Reactive hyperglycaemia in patients with acute stroke. J Neurol Sci 1976;29: 267-275.
10. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycaemia and prognosis of stroke in non-diabetic patients: a systematic overview. Stroke 2001;32 :2426-2432.
11. Scott JF, Robinson GM, French JM, et al: Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet 1999;353:376-377.
12. Allport L, Baird T, Butcher K, et al: Frequency and temporal profile of post stroke hyperglycaemia using continuous glucose monitoring. Diabetes Care 2006;29:1839-1844.
13. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003;26(suppl 1):s5-s20.
14. Scott JF, Robinson GM, French JM, et al: Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet 1999;353:376-377.
15. O'Neill PA, Davies I, Fullerton KJ, Bennett D: Stress hormone and blood glucose response following acute stroke in the elderly. Stroke 1991;22:842-847.
16. Murros K, Fogelholm R, Kettunen S, Vuorela AL: Serum cortisol and outcome of ischemic brain infarction. J Neurol Sci 1993;116: 12-17.
17. van Kooten F, Hoogerbrugge N, Naarding P, Koustald PJ: Hyperglycaemia in the acute phase of stroke is not caused by stress. Stroke 1993;24:1129-1132.
18. Sprafka JM, Virnig BA, Shahar E, et al: Trends in diabetes prevalence among stroke patients and the effect of diabetes on stroke survival: the Minnesota Heart Survey. Diabetes Med 1994;11:678-684.
19. Weir CJ, Murray GD, Dyker AG, Lees KR: Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term fol low up study. BMJ 1997;314: 1303-1306.
20. Quast MJ, Wei J, Huang N, et al: Perfusion deficit parallels exacerbation of cerebral ischaemia/reperfusion injury in hyperglycaemic rats. J Cereb Blood Flow Metab 1997; 17:553-559.
21. Williams LS, Rotich J, Qi R, et al: Effects of admission hyperglycaemia on mortality and costs in acute ischemic stroke. Neurology 2002;59:67-71.
22. Fuentes B, Diez-Tejedor E: General care in the stroke: relevance of glycemia and blood pressure levels. Cerebrovasc Dis 2007;24 (suppl 1):s134-s142.
23. Candelise L, Landi G, Orazio EN, Boccardi E: Prognostic significance of hyperglycaemia in acute stroke. Arch Neurol 1985;42: 661-663.
24. Fuentes B, Diez-Tejedor E, Castillo J, et al: Prognostic value of glucose levels in acute stroke outcome: GLIA study. Stroke 2006;37: 625.
25. Baird TA, Parsons MW, Phanh T, et al: Persistent post stroke hyperglycaemia is associated with infarct expansion and worse clinical outcome. Stroke 2003;34:2208-2214.
26. Kushner M, Nencini P, Reivich M, et al: Relation of hyperglycaemia early in ischaemic brain infarction to cerebral anatomy, metabolism and clinical outcome. Ann Neurol 1990;28:129-135.
27. 2 modulation on cortical intracellular acidosis, NADH redox state and infarction in the ischaemic penumbra. Stroke 1999;30:160-170.
28. Nazir FS, Alem M, Small M, Connell JM, Lees KR, Walters MR, Cleland SJ: Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with type 2 diabetes. Diabetes Med 2006;23:398-402.
29. Dandona P, James IM, Newbury PA, Wolard Ml, Beckett AG: Cerebral blood flow in diabetes mellitus: evidence of abnormal cerebrovascular reactivity. BMJ 1978;2:325-326.
30. Shechter M, Merz CN, Paul-Labrador MJ, Kaul S: Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease. J Am Col Cardiol 2000;35: 300-307.
31. Garg R, Chaudhuri A, Munschauer F, Dandona P: Hyperglycaemia, insulin and acute ischaemic stroke. Stroke 2006;37:267-273.
32. Kerman WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Horwitz RI: Insulin resistance and risk for stroke. Neurology 2002;59: 809-815.
33. Kernan WN, Inzucchi SE, Viscoli CM, et al: Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke. Neurology 2003;60:1447-1451.
34. Murros K, Fogelholm R, Kettunen S, Vuorela AL, Valve J: Blood glucose, glycosylated haemoglobin and outcome of ischemic brain infarction. J Neurol Sci 1992;111:59-64.
35. Song EC, Chu K, Jeong SW, Jung KH, Kim SH, Kim M, Yoon BW: Hyperglycaemia exacerbates brain oedema and perihaematomal cell death after intracerebral haemorrhage. Stroke 2003;34:2215-2220.
36. Berger L, Hakim AM: The association of hyperglycaemia with cerebral oedema in stroke. Stroke 1986;17:865-871.
37. Bruno A, Levnie SR, Frankel MR, Brott TG, Kwiatkowski TG, Fineberg SE; for the NINDS rt-PA stroke study group: Admission glucose level and clinical outcomes in the NINDS rt-PA stroke trial. Neurology 2002; 59:669-674.
38. Lilienfield DE, Vlahov D, Tenney JH, McLaughlin JS: Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery. Am J Infect Cont 1998; 16:3-6.
39. Ortega-casarrubios MA, Fuentes B, San Jose B, Martinez P, Diez-Tejedor E: Influence of previous diagnosis of diabetes mellitus on stroke severity and in hospital outcome in acute cerebral infarction. Neurologia 2007; 22:426-433.
40. Jaillard A, Cornu C, Durieux A, Moulin T, Boutitie F, Lees KR, Hommel M: Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke 1999;30:1326-1332.
41. Kase CS, Furlan AJ, Wechsler LR, et al: Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 2003;57:1603-1610.
42. Ribo M, Molina C, Montaner J, et al: Acute hyperglycaemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke 20 05;36:1705-1709.
43. Kent TA, Soukup VM, Fabian RH: Heterogeneity affecting outcome from acute stroke therapy: making reperfusion worse. Stroke 2001;32:2318-2327.
44. Ribo M, Molina CA, Delgado P, et al: Hyperglycaemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA. J Cereb Blood Flow Metab 2007;27: 1616-1622.
45. Wilson M, Weinreb J, Hoo GWS: Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care 2007;30:1005-1011.
46. Sawin C: The sliding scale of insulin use. Arch Intern Med 1997;157:489.
47. Gray CS, Hildreth AJ, Alberti GK, O'Connell JE; on behalf of the GIST collaborators: Post-stroke hyperglycaemia natural history and immediate management. Stroke 2004;35: 122-126.
48. Bland DK, Fankhanel Y, Langford E, et al: Intensive versus modified conventional control of blood glucose level in medical intensive care patients: a pilot study. Am J Crit Care 2005;14:370-376.
49. Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE: Unrecognized diabetes among hospitalized patients. Diabetes Care 1998;21: 246-249.
50. Pittas AG, Siegel RD, Lau J: Insulin therapy for critically ill hospitalized patients: a metaanalysis of randomised controlled trials. Arch Int Med 2004;164:2005-2011.
51. Van den Berghe G, Wilmer A, Hermans G, et al: Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-461.
52. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patient. N Engl J Med 2001; 345:1359-1367.
53. Malmberg K, Ryden L, Efendic S, et al: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction - effects on mortality at one year. J Am Coll Cardiol 1995;26:57-65.
54. Malmberg K, Ryden L, Wedel H, et al: Intense metabolic control by means of insulin in diabetes mellitus and acute myocardial infarction (DIGAMI2): effects on mortality and morbidity. Eur Heart J 2005; 26: 650-661.
55. Dormandy JA, Charbonnel B, Eckland DJ; on behalf of the PROactive investigators: Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (Prospective Pioglitazone Clinical Trial in Macrovascular Events): a randomised controlled trial. Lancet 2005; 366:1279-1289.
56. Wilcox R, Bousser MG, Betteridge DJ, et al: Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04). Stroke 2007;38:865-873.
57. Lago RM, Singh PP, Nesto RW: Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet 2007;370: 1129-1136.
58. Skyler JS: PROactive: A sad tale of inappropriate analysis and unjustified interpretation. Clin Diabetes 20 06; 24: 63-65.
59. Home P: Safety of very tight blood glucose control in ty pe 2 diabetes. BMJ 2008;336: 458-459.
60. Langhorne P, Pollock A; for the Stroke Unit Trialists Collaboration: What are the components of effective stroke unit care. Age Ageing 2002;31:365-371.
61. Gray CS, Hildreth AJ, Sandercock PA, et al: Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007;6:397-406.
62. Walters MR, Weir CJ, Lees K: A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis 2006;22:116-122.
63. Bruno A, Saha C, Williams LS, Shankar R: IV insulin during acute cerebral infarction in diabetic patients. Neurology 2004;62: 1441-1442.
64. Bruno A, Kent TA, Coull BM, et al: Treatment of Hyperglycaemia in Ischaemic Stroke (THIS): a randomized pilot trial. Stroke 2008;39:384-389.
65. The Intercollegiate Working Party for Stroke, Royal College of Physicians of London: National Clinical Guidelines for Stroke. Suffolk, Tavenham Press, 2000.
66. The European Stroke Organisation (ESO) Executive Committee and ESO Writing Committee: Guidelines for the Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. Cerebrovasc Dis 2008; 25:457-507.
67. Adams HP, del Zoppa G, Alberts MJ, et al; for the American Heart Association, American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: Guidelines for the early management of adults with ischaemic stroke. Stroke 2007;38:16 5 5-1711.